Sanders Corazon (Corsee) D. 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Jun 10, 2024
Insider Transaction Report
Form 4
Sanders Corazon (Corsee) D.
Director
Transactions
- Sale
Common Stock
2024-06-10$41.10/sh−1,737$71,391→ 7,248 total
Footnotes (1)
- [F1]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.